Published by Iain Gilbert on 25th May 2021
(Sharecast News) - Pharmaceutical company Sareum said on Tuesday that Covid-19 has continued to impact the contract research organisations it was working to complete pre-clinical development of its SDC-1801 drug candidate for autoimmune disease.
URL: http://www.digitallook.com/dl/news/story/31871082/...